Novartis radioligand therapy Lutathera gets USFDA nod for pediatric patients with gastroenteropancreatic neuroendocrine tumors Ruchika Sharma25 April 2024 12:14 PM ISTBasel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved Lutathera (USAN: lutetium Lu 177 dotatate / INN:...
Ultrasound guided radiofrequency ablation safer than surgery against pancreatic insulinoma Jacinthlyn Sylvia28 March 2023 1:45 AM ISTFor the treatment of pancreatic insulinoma (PI), Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is both safer and more successful than...
Cipla bags USFDA nod for Lanreotide Injection Ruchika Sharma20 Dec 2021 12:54 PM ISTMumbai: Cipla Limited along with its subsidiary Cipla USA, Inc., announced that it has received final approval for its Lanreotide Injection, from the...
